Pharmena S.A.
PHR.WA · WSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | PLN 35,301 | PLN 33,000 | PLN 50,788 | PLN 42,660 |
| - Cash | PLN 356 | PLN 209 | PLN 841 | PLN 1,745 |
| + Debt | PLN 184 | PLN 202 | PLN 223 | PLN 244 |
| Enterprise Value | PLN 35,129 | PLN 32,993 | PLN 50,170 | PLN 41,159 |
| Revenue | PLN 407 | PLN 386 | PLN 393 | PLN 88 |
| % Growth | 5.4% | -1.8% | 346.6% | – |
| Gross Profit | PLN 345 | -PLN 677 | PLN 301 | PLN 75 |
| % Margin | 84.8% | -175.4% | 76.6% | 85.2% |
| EBITDA | -PLN 651 | -PLN 846 | -PLN 441 | -PLN 944 |
| % Margin | -160% | -219.2% | -112.2% | -1,072.4% |
| Net Income | -PLN 690 | -PLN 700 | -PLN 489 | -PLN 118 |
| % Margin | -169.5% | -181.3% | -124.4% | -134.1% |
| EPS Diluted | 0 | -0.07 | -0.044 | -0.011 |
| % Growth | 100% | -59.5% | -314.2% | – |
| Operating Cash Flow | -PLN 820 | -PLN 919 | -PLN 839 | -PLN 11 |
| Capital Expenditures | -PLN 23 | -PLN 81 | -PLN 9,049 | -PLN 67 |
| Free Cash Flow | -PLN 843 | -PLN 1,000 | -PLN 9,888 | -PLN 78 |